Subscribe to stay informed!
Actress Jennifer Aniston talks about her struggles with insomnia in a commercial for Swiss pharmaceutical company Idorsia, writes John George for the Philadelphia Business Journal…
Weeks after canceling its IPO plans, Exton-based Castle Creek Biosciences has acquired Novavita Thera, a Minnesota-based preclinical gene therapy company that focuses on…
20n Bio, an artificial intelligence-powered drug discovery company based in Malvern, recently raised $3.3 million to advance its work in designing new therapeutic…
Malvern-based Galera Therapeutics has seen its stock price double following the announcement of “corrected” results from late-stage testing of avasopasem, the biopharmaceutical company…
Devon native Drew Endy, a professor of bioengineering at Stanford University, is a star in the emerging synthetic biology field, writes Steve Lohr for The…
Exton-based Immunome has submitted an application with the FDA to start human testing its “antibody cocktail” as a potential COVID-19 treatment, writes John…
Boston-based Griffith Properties, a real estate company backed by DRA Advisors, has purchased five buildings at the Oaklands Corporate Center in Exton for $43…
Deloitte has published its latest report of the 500 fastest-growing technology and life sciences companies in North America, and AscellaHealth in Berwyn is among…
According to the Centers for Disease Control, a batch of vials labeled “smallpox” were found in a freezer at a Merck facility in Upper Gwynedd…
Malvern-based Ocugen submitted an investigational new drug application with the FDA. It seeks approval to start a Phase-3 clinical trial that would evaluate…
Four Chester County companies are among the 20 Philadelphia-area public companies that grew the most during the pandemic, writes Ryan Mulligan for the Philadelphia…
Malvern-based VenatoRx Pharmaceuticals has teamed with a Swiss pharmaceutical company to work on a new class of antibiotics that would address the growing threat…
Endo International — based in Dublin, Ireland, with a U.S. headquarters in Malvern — has launched a marketing campaign to promote Xiaflex. The flagship product addresses…
Exton-based Castle Creek Biosciences has received a $1.8 million grant from the Food and Drug Administration to support late-stage clinical testing of…
Malvern-based Galera Therapeutics’ stock fell by more than 70 percent after the biopharmaceutical firm announced that its cancer drug candidate did not meet its…
Before we send you to this site, please subscribe to our daily newsletter.